Loading...
XNYS
MED
Market cap148mUSD
Jun 16, Last price  
13.54USD
1D
4.31%
1Q
-6.94%
Jan 2017
-67.48%
Name

Medifast Inc

Chart & Performance

D1W1MN
XNYS:MED chart
P/E
71.17
P/S
0.25
EPS
0.19
Div Yield, %
—
Shrs. gr., 5y
-1.98%
Rev. gr., 5y
-3.33%
Revenues
602m
-43.80%
40,129,00074,086,00083,779,000105,445,000165,618,000257,552298,189,000356,706,000356,886,000285,285,000272,773,000274,534,000301,563,000501,003,000713,672,000934,842,0001,526,087,0001,598,577,0001,072,054,000602,463,000
Net income
2m
-97.90%
2,727,0005,082,0003,837,0005,435,00011,963,00019,61118,541,00015,876,00023,969,00013,181,00020,058,00017,835,00027,721,00055,789,00077,916,000102,859,000164,031,000143,568,00099,415,0002,091,000
CFO
24m
-83.42%
3,213,0005,845,0007,954,0005,496,00020,313,00028,769,00034,870,00040,264,00042,360,00025,536,00029,411,00025,350,00043,237,00060,816,00084,261,000145,196,00094,545,000194,570,000147,657,00024,476,000
Dividend
Sep 18, 20231.65 USD/sh
Earnings
Aug 04, 2025

Profile

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
URL
https://medifastinc.com/
IPO date
Dec 30, 1993
Employees
874
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
602,463
-43.80%
1,072,054
-32.94%
1,598,577
4.75%
Cost of revenue
157,840
950,252
1,418,271
Unusual Expense (Income)
NOPBT
444,623
121,802
180,306
NOPBT Margin
73.80%
11.36%
11.28%
Operating Taxes
1,696
29,382
40,491
Tax Rate
0.38%
24.12%
22.46%
NOPAT
442,927
92,420
139,815
Net income
2,091
-97.90%
99,415
-30.75%
143,568
-12.48%
Dividends
(715)
(73,017)
(71,620)
Dividend yield
0.37%
9.95%
5.51%
Proceeds from repurchase of equity
(836)
(6,960)
(127,961)
BB yield
0.43%
0.95%
9.84%
Debt
Debt current
6,182
11,770
5,776
Long-term debt
26,068
38,139
46,326
Deferred revenue
Other long-term liabilities
16,566
Net debt
(58,678)
(100,132)
(35,589)
Cash flow
Cash from operating activities
24,476
147,657
194,570
CAPEX
(7,454)
(6,483)
(16,681)
Cash from investing activities
(26,520)
(61,047)
(11,414)
Cash from financing activities
(1,515)
(79,789)
(199,581)
FCF
394,375
100,953
178,771
Balance
Cash
90,928
150,041
87,691
Long term investments
Excess cash
60,805
96,438
7,762
Stockholders' equity
176,962
174,908
139,887
Invested Capital
165,429
115,378
187,900
ROIC
315.47%
60.95%
74.97%
ROCE
196.53%
57.50%
100.68%
EV
Common stock shares outstanding
10,963
10,921
11,276
Price
17.62
-73.79%
67.22
-41.73%
115.35
-44.92%
Market cap
193,168
-73.69%
734,110
-43.56%
1,300,687
-47.43%
EV
134,490
633,978
1,265,098
EBITDA
456,531
134,909
191,286
EV/EBITDA
0.29
4.70
6.61
Interest
701
Interest/NOPBT
0.39%